Christopher L. Jordan
Consigliere Generale presso CHIMERIX, INC.
Profilo
Christopher L.
Jordan is currently the Vice President-Regulatory Affairs at Chimerix, Inc. He previously worked as the Senior Global Program Regulatory Director at Novartis AG, Vice President-Regulatory Affairs at Endocyte, Inc., and Principal at Eli Lilly & Co. He holds a graduate degree from George Washington University and an undergraduate degree from Purdue University.
Posizioni attive di Christopher L. Jordan
| Società | Posizione | Inizio |
|---|---|---|
| CHIMERIX, INC. | Consigliere Generale | 08/08/2022 |
Precedenti posizioni note di Christopher L. Jordan
| Società | Posizione | Fine |
|---|---|---|
| ENDOCYTE, INC. | Consigliere Generale | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| NOVARTIS AG | Consigliere Generale | - |
Formazione di Christopher L. Jordan
| George Washington University | Graduate Degree |
| Purdue University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Aziende private | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Borsa valori
- Insiders
- Christopher L. Jordan
